Literature DB >> 25224357

Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: comparison of biomass production and metabolic activity and development of cut-off points.

Laura Judith Marcos-Zambrano1, Pilar Escribano2, Emilio Bouza3, Jesús Guinea4.   

Abstract

Biofilm production in Candida spp. can be studied by measuring the biomass produced after application of crystal violet stain or by measuring metabolic activity with XTT. Our study is the first in which crystal violet and XTT are compared to analyze the ability of clinically relevant Candida and non-Candida species to produce biofilm. We studied 577 isolates causing fungemia in 512 patients admitted from January 2007 to July 2013. Based on the biomass production measured by crystal violet and the metabolic activity measured by XTT, strains were divided into terciles to establish tentative cut-offs to classify isolates as being low, moderate, or high biofilm-forming and as having low, moderate, or high metabolic activity. Considerable variability in biofilm production and metabolic activity was found both between species and within species. C. tropicalis showed the highest biomass production, whereas C. glabrata showed the highest metabolic activity, and non-Candida species isolates showed the lowest metabolic activity (P<0.0023). The isolates were classified as low metabolic activity, moderate metabolic activity, and high metabolic activity according to their cut-offs by XTT (<0.097, 0.097-0.2, and >0.2) and as low biofilm-forming, moderate biofilm-forming, and high biofilm-forming according to their cut-offs by crystal violet (<0.44, 0.44-1.17, and >1.17). The overall categorical agreement between the procedures was 43.7%, which increased to >50% for C. albicans and C. parapsilosis. XTT and crystal violet are complementary procedures for the study of biofilm production.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Biofilm; Biofilm-forming; Candida; Candidemia; Crystal violet; Cut-off; Non-candida; XTT

Mesh:

Substances:

Year:  2014        PMID: 25224357     DOI: 10.1016/j.ijmm.2014.08.012

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  28 in total

1.  The Activities of Adhesion and Biofilm Formation by Candida tropicalis Clinical Isolates Display Significant Correlation with Its Multilocus Sequence Typing.

Authors:  Shuan Bao Yu; Wen Ge Li; Xiao Shu Liu; Jie Che; Jin Xing Lu; Yuan Wu
Journal:  Mycopathologia       Date:  2017-01-13       Impact factor: 2.574

2.  Mutant Prevention Concentration and Mutant Selection Window of Micafungin and Anidulafungin in Clinical Candida glabrata Isolates.

Authors:  Pilar Escribano; Jesús Guinea; María Ángeles Bordallo-Cardona; Laura Judith Marcos-Zambrano; Carlos Sánchez-Carrillo; Elia Gómez G de la Pedrosa; Rafael Cantón; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

3.  Vaccination with Secreted Aspartyl Proteinase 2 Protein from Candida parapsilosis Can Enhance Survival of Mice during C. tropicalis-Mediated Systemic Candidiasis.

Authors:  Manisha Shukla; Soma Rohatgi
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

4.  Comparison of Switching and Biofilm Formation between MTL-Homozygous Strains of Candida albicans and Candida dubliniensis.

Authors:  Claude Pujol; Karla J Daniels; David R Soll
Journal:  Eukaryot Cell       Date:  2015-10-02

5.  Candidemia by Candida parapsilosis in a neonatal intensive care unit: human and environmental reservoirs, virulence factors, and antifungal susceptibility.

Authors:  Ralciane de Paula Menezes; Sávia Gonçalves de Oliveira Melo; Meliza Arantes Souza Bessa; Felipe Flávio Silva; Priscila Guerino Vilela Alves; Lúcio Borges Araújo; Mário Paulo Amante Penatti; Vânia Olivetti Steffen Abdallah; Denise von Dollinger de Brito Röder; Reginaldo Dos Santos Pedroso
Journal:  Braz J Microbiol       Date:  2020-02-15       Impact factor: 2.476

6.  Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia.

Authors:  Laura Judith Marcos-Zambrano; Mireia Puig-Asensio; Felipe Pérez-García; Pilar Escribano; Carlos Sánchez-Carrillo; Oscar Zaragoza; Belén Padilla; Manuel Cuenca-Estrella; Benito Almirante; M Teresa Martín-Gómez; Patricia Muñoz; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

7.  Virulence Factors and Antifungal Susceptibility in Candida Species Isolated from Dermatomycosis Patients.

Authors:  Victor Galvão Mello; Heloisa Escudeiro; Ana Carolina Villas Bôas Weckwerth; Maria Izilda Andrade; Ana Elisa Fusaro; Eloise Brasil de Moraes; Luciana da Silva Ruiz; Ida Maria Foschiani Dias Baptista
Journal:  Mycopathologia       Date:  2020-11-20       Impact factor: 2.574

8.  Candida tropicalis Biofilms: Biomass, Metabolic Activity and Secreted Aspartyl Proteinase Production.

Authors:  Melyssa Negri; Sónia Silva; Isis Regina Grenier Capoci; Joana Azeredo; Mariana Henriques
Journal:  Mycopathologia       Date:  2015-11-16       Impact factor: 2.574

9.  Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.

Authors:  Laura Judith Marcos-Zambrano; Marta Gómez-Perosanz; Pilar Escribano; Oscar Zaragoza; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

10.  In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.

Authors:  Małgorzata Prażyńska; Tomasz Bogiel; Eugenia Gospodarek-Komkowska
Journal:  Folia Microbiol (Praha)       Date:  2017-10-05       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.